Access cutting-edge cmv infection treatment through this clinical trial at a research site in St Louis. Study-provided care at no cost to qualified participants.
Access cmv infection specialists in St Louis at no cost
This study follows strict safety protocols and ethical guidelines
All study-related cmv infection treatment provided free
Patients with moderate or severe CMV disease less than 21 days old who have a maternal donor who has a CMV response to the peptivators will be screened. All patients will receive treatment with valganciclovir or ganciclovir. There is a safety run in with treatment with CMV CTLs in cohort 1 and if found to be safe, will proceed to cohort 2 for randomization to receive antiviral therapy with or without CMV CTLs. Funding source: FDA OOPD
Sponsor: New York Medical College
Check if you qualify for this cmv infection clinical trial in St Louis, MO
If you're searching for cmv infection treatment options in St Louis, MO, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our St Louis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced cmv infection specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.